UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

SCHEDULE 13G

(Amendment No. 3)*

 

Under the Securities Exchange Act of 1934

 

AMERICAN BIO MEDICA CORPORATION

(Name of Issuer)

 

Common Stock, $ .01 par value

(Title of Class of Securities)

 

024600 10 8

(CUSIP Number)

 

November 18, 2021

(Date of Event which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

  ¨ Rule 13d-1(b)
  x Rule 13d-1(c)
  ¨ Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

 

 

CUSIP No. 024600 10 8 13G  
         
1.  

NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

Stuart Sternberg

XXXXXXXXXX

   
2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a)    ¨
(b)    ¨ Not Applicable. 		   
3.   SEC USE ONLY
  		   
4.   CITIZENSHIP OR PLACE OF ORGANIZATION
 
U.S.A. 		   
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH   5.   SOLE VOTING POWER
 
4,444,964
  6.   SHARED VOTING POWER
 
 0
  7.   SOLE DISPOSITIVE POWER
 
4,444,964
  8.   SHARED DISPOSITIVE POWER
 
0 
9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

4,444,964 		   
10.   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see instructions)    ¨ 		   
11.   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

9.3% based on 47,598,476 outstanding shares as of November 18, 2021 reported in the issuer’s Form 10-Q for the quarterly period ended September 30, 2021 filed with the SEC on November 18, 2021 		   
12.   TYPE OF REPORTING PERSON (see instructions)

IN 		   
         
                         

 

 

 

 

 

 

CUSIP No. 024600 10 8 13G/A  

 

Item 1.

 

  (a) Name of Issuer
American Bio Medica Corporation
     
  (b)

Address of Issuer’s Principal Executive Offices
122 Smith Road

Kinderhook, New York 12106

     

Item 2.

 

  (a) Name of Person Filing
Stuart Sternberg
     
  (b)

Address of the Principal Office or, if none, residence
555 5th Ave NE, Unit 1043

St Petersburg  FL 33701

     
  (c) Citizenship
U.S.A.
     
  (d) Title of Class of Securities
Common Stock, $.01 par value
     
  (e) CUSIP Number
024600 10 8
     

Item 3.  If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

 

  (a) ¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
       
  (b) ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
       
  (c) ¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
       
  (d) ¨ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
       
  (e) ¨ An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
       
  (f) ¨ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
       
  (g) ¨ A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
       
  (h) ¨ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
       
  (i) ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
       
  (j) ¨ Group, in accordance with §240.13d-1(b)(1)(ii)(J).

 

 

 

 

Item 4.  Ownership.

 

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

         
  (a)   Amount beneficially owned:  4,444,964
         
  (b)   Percent of class:  9.3% based on 47,598,476 outstanding shares as of November 18, 2021 reported in the issuer’s Form 10-Q for the quarterly period ended September 30, 2021 filed with the SEC on November 18, 2021
         
  (c)   Number of shares as to which the person has:  
         
      (i) Sole power to vote or to direct the vote:  4,444,964
         
      (ii) Shared power to vote or to direct the vote:  0
         
      (iii) Sole power to dispose or to direct the disposition of: 4,444,964
         
      (iv) Shared power to dispose or to direct the disposition of: 0
         

Item 5.  Ownership of Five Percent or Less of a Class.

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following     ¨.

 

Item 6.  Ownership of More than Five Percent on Behalf of Another Person.

  

Not applicable.

 

Item 7.  Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

  

Not applicable.

 

Item 8.  Identification and Classification of Members of the Group.

 

Not applicable.

  

Item 9.  Notice of Dissolution of Group.

 

Not applicable.

  

Item 10.  Certification.

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

 

 

 

 

  

CUSIP No. 024600 10 8 13G  

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 

 

November 29, 2021

Date

   
 

/s/ Stuart Sternberg

Signature 

   
 

Stuart Sternberg

Name/Title

   

 

 

American Bio Medica (CE) (USOTC:ABMC)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more American Bio Medica (CE) Charts.
American Bio Medica (CE) (USOTC:ABMC)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more American Bio Medica (CE) Charts.